Immunotherapy, No Pre-Immunization, HIV(+) Patients JP
Country:
Japan
Docket No:
436313-001510
Publication Number:
2020-515234
Patent Expiry:
01/09/2038
Claims Scope:
Patent issued April 10, 2023.
Sequence-specific Method of Manufacture and Composition Use (treatment) Claims
– method of producing transduced PBMS (claim 1)
– composition for treating HIV infection (claim 16)
– sequence specific limitations include:
- 90% SEQ ID NO 31: CCR5, Vif and Tat (microRNA backbone plus guide, in order)
- 90% SEQ ID NO: 97, 6 and 7 (CCR5, Vif and Tat guide, any order)
*note no claims to SEQ ID NOS 1, 2 and 3/108 (CCR5, Vif and Tat backbone plus guide)